Ahmad, Saleem <br/><br/>
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Feb 2010 
 - 1128-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2009.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Anti-Obesity Agents--administration & dosage<br/>Eating--drug effects<br/>Humans<br/>Male<br/>Obesity--drug therapy<br/>Protein Binding--physiology<br/>Quinazolinones--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Serotonin, 5-HT2C--metabolism<br/>Serotonin 5-HT2 Receptor Agonists<br/>Serotonin Receptor Agonists--administration & dosage